|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsor: | Luzerner Kantonsspital |
|---|---|
| Information provided by: | Luzerner Kantonsspital |
| ClinicalTrials.gov Identifier: | NCT00114335 |
Purpose
This small cross-sectional epidemiological study is designed to evaluate the prevalence of the following parameters in hospitalized patients in a tertiary teaching hospital (medical department only):
| Condition |
|---|
|
Kidney Diseases Obesity |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Cross-Sectional |
| Official Title: | Prevalence of Impaired Renal Function in Medical Inpatients |
| Enrollment: | 352 |
| Study Start Date: | May 2005 |
| Study Completion Date: | July 2005 |
This small cross-sectional epidemiological study is designed to evaluate the prevalence of the following parameters in hospitalized patients in a tertiary teaching hospital (medical department only):
Eligibility| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
All patients hospitalized at the defined days (two days) at Kantonsspital Luzern, Department of Medicine
Inclusion Criteria:
Contacts and Locations| Switzerland | |
| Kantonsspital Luzern | |
| Luzern, LU, Switzerland, 6000 | |
| Principal Investigator: | P Schmid, MD | Kantonsspital Luzern, Hematology |
| Study Director: | A G Fischer, MD | Kantonsspital Luzern, Nephrology |
| Study Chair: | W A Wuillemin, MD, PhD | Kantonsspital Luzern, Hematology |
More Information
| ClinicalTrials.gov Identifier: | NCT00114335 History of Changes |
| Other Study ID Numbers: | LMWHplus_1 |
| Study First Received: | June 14, 2005 |
| Last Updated: | October 9, 2008 |
| Health Authority: | Switzerland: Swissmedic |
|
low molecular weight heparin unfractionated heparin |
|
Kidney Diseases Obesity Urologic Diseases Overnutrition Nutrition Disorders Overweight Body Weight Signs and Symptoms Heparin, Low-Molecular-Weight |
Anticoagulants Hematologic Agents Therapeutic Uses Pharmacologic Actions Fibrinolytic Agents Fibrin Modulating Agents Molecular Mechanisms of Pharmacological Action Cardiovascular Agents |